Advaxis Competitors and Similar CompaniesClear all
Advaxis's competitors and similar companies include Marker Therapeutics, KemPharm, Streamline Health and MOLOGEN.
 Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. |  Streamline Health Streamline Health Solutions is a company that develops revenue cycle management software for healthcare providers. |  MOLOGEN MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases. | ||
Founding Date | Founding Date 2002 | Founding Date 2018 | Founding Date 2006 | Founding Date 1989 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Princeton, US HQ | Locations Houston, US HQ | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US | Locations Alpharetta, US HQ | Locations Berlin, DE HQ |
Employees | Employees 3540% decrease | Employees 888% decrease | Employees 333% increase | Employees 7824% decrease | Employees 4710% decrease |
Valuation ($) | Valuation ($) 2.4 m | Valuation ($) 36.5 m | Valuation ($) 200.5 m | Valuation ($) 9.1 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $13k (FY, 2023) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $106.5m (FY, 2025) | Revenue (est.) $17.9m (FY, 2025) | Revenue (est.) €81k (FY, 2019) |
Cost of goods | Cost of goods $13k (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods €2m (FY, 2019) |
Net income | Net income ($48.1m) (FY, 2023) | Net income ($12.2m) (FY, 2025) | Net income $83.2m (FY, 2025) | Net income ($10.2m) (FY, 2025) | Net income (€10.3m) (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised $ 50.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 12m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Marker Therapeutics
HQ
Houston, US
Employees
8
Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.
View companyKemPharm
HQ
Kissimmee, US
Employees
33↑ 3% increase
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
View companyStreamline Health
HQ
Alpharetta, US
Employees
78↓ 24% decrease
Streamline Health Solutions is a company that develops revenue cycle management software for healthcare providers.
View companyMOLOGEN
HQ
Berlin, DE
Employees
47↓ 10% decrease
MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases.
View company